Health
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial – The Lancet
BBV152 was highly efficacious against laboratory-confirmed symptomatic COVID-19 diseasein adults. Vaccination was well tolerated…
We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site.Copyright © 2021 Elsevier Inc. except certain content provided by third parties. The…
Continue Reading
-
Noosa News16 hours agoNRL legend Trevor Gillmeister charged with assaulting police officer at Brisbane pub
-
Business19 hours agoMacquarie tips more than 20% upside for this ASX mining stock
-
Noosa News17 hours agoSchools ban e-bikes | Noosa Today
-
General16 hours agoCatholic Education Tasmania to close six schools, with three others partially closed, due to coloured sand recall